CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures

Neurology

Volumn 84, Issue 9, 2015, Pages 951-958

  Thomas, Rhys H ^a,b   Zhang, Lin Mei ^a,c   Carvill, Gemma L ^d   Archer, John S ^a   Heavin, Sinéad B ^a   Mandelstam, Simone A ^a,e   Craiu, Dana ^f   Berkovic, Samuel F ^a   Gill, Deepak S ^g   Mefford, Heather C ^d   Scheffer, Ingrid E ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 2; DNA BINDING PROTEIN; UNCLASSIFIED DRUG; CHD2 PROTEIN, HUMAN;

ABSENCE SEIZURE; ADOLESCENT; ADULT; ARTICLE; ATONIC SEIZURE; ATYPICAL SEIZURE; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EYELID CLOSURE; EYELID DISEASE; EYELID MYOCLONIA; FEBRILE CONVULSION; FEMALE; GENE MUTATION; HUMAN; INTELLECTUAL IMPAIRMENT; LENNOX GASTAUT SYNDROME; MALE; MEDICAL HISTORY; MYOCLONIC ENCEPHALOPATHY; MYOCLONUS; MYOCLONUS SEIZURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PHOTOSENSITIVITY; PRIORITY JOURNAL; REFRACTORY SEIZURE; SEIZURE; SELF INDUCED SEIZURE; TELEVISION VIEWING; TONIC CLONIC SEIZURE; TONIC SEIZURE; VIDEORECORDING; ADVERSE EFFECTS; COHORT ANALYSIS; EPILEPSIES, MYOCLONIC; GENETICS; PATHOPHYSIOLOGY; PHOTOSTIMULATION; SEIZURES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; DNA-BINDING PROTEINS; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; PHOTIC STIMULATION; SEIZURES; YOUNG ADULT;

EID: 84924205565     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001305     Document Type: Article

References (24)

1. Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45:825-830.
2. Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501:217-221.
3. Suls A, Jaehn JA, Kecskes A, et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitivemyoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet 2013;93:967-975.
4. Mullen SA, Carvill GL, Bellows S, et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013;81:1507-1514.
5. th ed. Montrouge, France: John Libbey; 2012:166.
6. Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol 2013;48:355-362.
7. Doose H, Gerken H, Leonhardt R, Volzke E, Volz C. Centrencephalic myoclonic-astatic petit mal: clinical and genetic investigation. Neuropadiatrie 1970;2:59-78.
8. Doose H, Waltz S. Photosensitivity: genetics and clinical significance. Neuropediatrics 1993;24:249-255.
9. th ed. Montrouge, France: John Libbey; 2012:125-156.
10. Guerrini R, Aicardi J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J Clin Neurophysiol 2003;20:449-461.
11. Veredice C, Bianco F, Contaldo I, et al. Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case. Epilepsia 2009;50:1810-1815.
12. Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012;380:1674-1682.
13. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012;485:242-245.
14. Capelli LP, Krepischi AC, Gurgel-Giannetti J, et al. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. Eur J Med Genet 2012;55:132-134.
15. Li MM, Nimmakayalu MA, Mercer D, Andersson HC, Emanuel BS. Characterization of a cryptic 3.3Mb deletion in a patient with a "balanced t(15;22) translocation" using high density oligo array CGH and gene expression arrays. Am J Med Genet A 2008;146:368-375.
16. Dhamija R, Patterson MC, Wirrell EC. Epilepsy in children: when should we think neurometabolic disease? J Child Neurol 2012;27:663-671.
17. Lund C, Brodtkorb E, Røsby O, Rødningen OK, Selmer KK. Copy number variants in adult patients with Lennox-Gastaut syndrome features. Epilepsy Res 2013;105:110-117.
18. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 2013;9:e1003709.
19. Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 2005;65:3815-3822.
20. Kulkarni S, Nagarajan P, Wall J, et al. Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis. Am J Med Genet A 2008;146A:1117-1127.
21. Lund C, Brodtkorb E, Oye AM, Røsby O, Selmer KK. CHD2 mutations in Lennox-Gastaut syndrome. Epilepsy Behav 2014;33:18-21.
22. th ed. Montrouge, France: John Libbey; 2012:189-216.
23. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain 1997;120:479-490.
24. Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999;45:75-81.